Navigation Links
Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results
Date:2/28/2013

of $31.5 million from the sale of our equity interest in Optimer Biotechnology, Inc. (OBI).

At December 31, 2012, Optimer held cash, cash equivalents and short-term investments of $124.0 million.  This includes proceeds from the sale of our equity interest in OBI, which was completed in the fourth quarter.Optimer had 47.8 million shares outstanding on December 31, 2012.

"Healthcare policy is shifting to new ways to control healthcare spending, particularly in hospitals.  Many of our recent research initiatives, such as analyzing the cost burden of Clostridium difficile infection, are designed to assist hospitals to better understand the disease burden on their patients and institutions," said Dr. McKinnell.

As of December 31, 2012:

  • Inventory levels at wholesalers remain within the range of 14 to 28 days of demand
  • Approximately 2,750 hospitals had ordered DIFICID
  • About 83% of hospitals covered by Optimer have reordered DIFICID
  • Approximately 1,000 hospitals are estimated to have placed DIFICID on formulary
  • As a result of the management changes announced yesterday and processes and procedures in connection therewith, we have determined that the filing of our Form 10-K will be delayed.Conference Call and Webcast 
    The Company will host a conference call and webcast to discuss its fourth quarter and fiscal year 2012 financial results and provide a corporate update today at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

    The conference call may be accessed by dialing (877) 280-7280 for domestic callers and +1 (678) 825-8232 for international callers.  Please specify to the operator that you would like to join "Optimer's Financial Results Call."  The conference call will be webcast live under the Investors section of Optimer's website at www.optimerpharma.com, where it will be archived for
    '/>"/>

    SOURCE Optimer Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Optimer Pharmaceuticals Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer
    2. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year 2012 Financial Results
    3. Optimer Pharmaceuticals to Present at Leerink Swann Global Healthcare Conference
    4. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
    5. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
    6. Optimer Pharmaceuticals Reports Third Quarter 2012 Financial Results
    7. Optimer Pharmaceuticals to Present at September 2012 Investor Conferences
    8. Optimer Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
    9. Optimer Pharmaceuticals Appoints Stephen Newman to Its Board of Directors
    10. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2012 Financial Results
    11. Optimer Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/21/2013)... Fla. , May 21, 2013  Janssen ... safety results from the global Phase 3 PROMISE ... inhibitor simeprevir (TMC435) led to sustained virologic response ... in 79 percent of treatment-experienced genotype 1 chronic ... including all stages of liver fibrosis, when administered ...
    (Date:5/21/2013)... , May 21, 2013 Abaxis, Inc. (NasdaqGS: ... systems, announced today that Martin Mulroy ... Stifel Annual Dental & Veterinary Conference on Wednesday, May ... be held at Le Parker Meridien Hotel in ... Abaxis Abaxis develops, manufactures, markets and sells ...
    (Date:5/21/2013)...  BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC ... stem cell based therapies for various personal applications, announced ... and CEO, will be presenting at the Marcum MicroCap ... on Thursday, May 30, 2013 at the Grand Hyatt ... York City.  Mr. Weinreb,s presentation will take place at ...
    Breaking Medicine Technology:Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3
    ... July 19, 2011 Jonah and Dina Shacknai today issued the ... of police reports by the Paradise Valley Police Department: ... us had hoped, it did produce a wonderful son, Max, whom ... police reports are not reflective of the totality or the precise ...
    ... power of cosmetic lasers has grown by leaps and bounds ... laser treatments were first used, they were ablative lasers that ... younger skin below. However, the drawback to these early cosmetic ... of the skin down, which they did by stripping the ...
    Cached Medicine Technology:Renaissance Laser and Vein Institute Specializes in Revolutionary Laser Treatments for a Variety of Cosmetic Applications 2
    (Date:5/21/2013)... agency for scientific and technological research So Paulo Research ... announced an investment estimated in US$ 680 million to ... a period of up to eleven years, subject to ... , Funding for the 17 RIDCs will come from ... support personnel, and infrastructure). Host institutions will participate in ...
    (Date:5/21/2013)... York, New York (PRWEB) May 21, 2013 ... Vinci surgery robot lawsuit is nearing its conclusion ... According to Bloomberg.com, during closing statements yesterday, an attorney ... dealership, alleging the company wanted to tie sales and ... do all the training to keep control of surgeons, ...
    (Date:5/21/2013)... Today, Zane Benefits, Inc. published a ... accounts. Zane Benefits, which provides comprehensive and flexible alternatives ... in defined contribution and http://HRA ... to Zane Benefits’ website, the Affordable Care Act (known ... in 2010 and impacts many areas of health care ...
    (Date:5/21/2013)... Two executives from human resources and ... which strategies can be most effective to better manage ... members who are taking them, in an upcoming May ... to Manage Specialty Drugs to Reduce Costs and Ensure ... main driver for rising prescription drug costs, which are ...
    (Date:5/21/2013)... May 21, 2013 While North Carolina ... with comprehensive travel guides. Brunswick Plantation & Golf Resort ... that include access to 27 holes of "Top10" championship ... in North Carolina, knowing the Top 10 ... takes away the overwhelming task of selecting the course ...
    Breaking Medicine News(10 mins):Health News:Research at the cutting edge of knowledge 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2
    ... 30 Keck Graduate Institute (KGI) ... begin in January 2010, for those with an undergraduate degree ... skills before applying to medical school. , "We,re excited to ... medical professional," says Sheldon M. Schuster, PhD, KGI,s president. "Whether ...
    ... BEIJING, Sept. 30 /PRNewswire-Asia/ -- Sinovac Biotech ... products in China, announced today that,Sinovac has received its ... Ministry of Industry and Information Technology of the People,s,Republic ... purchase order,Sinovac is required to produce an additional 3 ...
    ... America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord ... ) focused on bringing the life saving potential ... nationwide and internationally, said today that it is opening ... laboratory in Las Vegas, as planned, the first ...
    ... National Breast Cancer Awareness Month and Topcor is introducing a ... October 5th, "Clipa for a Cure" is a special edition ... donate 10% of the retail price of every pink Clipa ... Society, breast cancer is the second leading cause of cancer ...
    ... Americans lack confidence that healthcare reform will deliver ... a survey released today by Thomson Reuters. , Forty-one ... make healthcare more affordable. When sorted by political ... divisions along party lines: 72 percent of Democrats said ...
    ... , LUDWIGSHAFEN, Germany, September 30 ... to cope with all the sustenance,we shove into it every ... the hardest substance that the human body produces. It consists ... questions of our Podcast listeners on Chemistry in our,everyday life. ...
    Cached Medicine News:Health News:KGI Establishes Post Baccalaureate Premedical Program 2Health News:Sinovac Obtains Second Order of H1N1 Vaccine from Chinese Central Government 2Health News:Sinovac Obtains Second Order of H1N1 Vaccine from Chinese Central Government 3Health News:Cord Blood America Opens Las Vegas Cryogenic Laboratory; Consolidates Offices in Nevada 2Health News:Cord Blood America Opens Las Vegas Cryogenic Laboratory; Consolidates Offices in Nevada 3Health News:'Clipa for a Cure': New Pink Instant Handbag Hanger Benefits Breast Cancer Research 2Health News:Thomson Reuters Survey: Americans Skeptical That Healthcare Reform Will Improve Quality or Affordability 2Health News:BASF Podcast: The Chemical Reporter - Why Does Fluoride Make Your Teeth Hard? 2Health News:BASF Podcast: The Chemical Reporter - Why Does Fluoride Make Your Teeth Hard? 3
    ... This comprehensive guide provides ... drug administration information in a ... revised 2006 edition includes the ... FDA with key nursing implications ...
    Alphabetically organized monographs on more than 1,000 generic and 3,000 trade name drugs....
    Nursing2006 Drug Handbook Entries include Alerts, dosage adjustments for specific populations, I.V. administration, off-label indications, adverse reactions, and more....
    The mission of AHFS DI Essentials (American Hospital Formulary Service) is to provide an evidence-based foundation for safe and effective drug therapy....
    Medicine Products: